EP4249069
Vatnskennd samsetning sem samanstendur af 1-(4-{[4-(dímetýlamínó)píperidín-1-ýl]karbónýl}fenýl)-3-[4-(4,6-dímorfólín-4-ýl-1,3,5-tríasín-2-ýl)fenýl]úreu
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
4.6.2019EP published:
19.11.2025EP application number:
23176968.8
EP translation filed:
2.1.2026Grant published:
11.2.2026EPO information:
European Patent Register
Max expiry date:
3.6.2039Expiry date:
3.6.2026
Title in English:
AQUEOUS FORMULATION COMPRISING 1-(4-{[4-(DIMETHYLAMINO)PIPERIDIN-1-YL]CARBONYL}PHENYL)-3-[4-(4,6-DIMORPHOLIN-4-YL-1,3,5-TRIAZIN-2-YL)PHENYL]UREALanguage of the patent:
English
Timeline
Today
4.6.2019EP application
19.11.2025EP Publication
2.1.2026Translation submitted
11.2.2026Registration published
3.6.2026Expires
Owner
Name:
Pfizer Inc.Address:
66 Hudson Boulevard East, New York, NY 10001-2192, US
Inventor
Name:
HUSSEY, James JosephAddress:
Sandwich, CT13 9NJ, GB
Name:
BRIGHT, Andrew GilbertAddress:
Sandwich, CT13 9NJ, GB
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
201862681722 PDate:
7.6.2018Country:
US
Number:
201862754651 PDate:
2.11.2018Country:
US
Number:
201962796133 PDate:
24.1.2019Country:
US
Number:
201962841882 PDate:
2.5.2019Country:
US
Classification
Categories:
A61K 9/08, A61K 9/19, A61K 47/12, A61K 47/40, A61K 31/5377, A61P 35/00, A61K 9/00